The past three decades have borne witness to many advances in the understanding of the
molecular biology and treatment of nasopharyngeal carcinoma (NPC), an Epstein–Barr virus …

Nasopharyngeal carcinoma is characterised by distinct geographical distribution and is
particularly prevalent in east and southeast Asia. Epidemiological trends in the past decade …

The NCCN Guidelines for Head and Neck (H&N) Cancers provide treatment
recommendations for cancers of the lip, oral cavity, pharynx, larynx, ethmoid and maxillary …

Nasopharyngeal carcinoma (NPC) is a disease with unique epidemiological features. The
distribution of the disease demonstrates a clear regional, racial and gender prevalence. In …

Radiation therapy (RT) plays a key role in curative-intent treatments for head and neck
cancers. Its use is indicated as a sole therapy in early stage tumors or in combination with …

Radiation therapy plays an integral role in the management of head and neck cancers
(HNCs). While most HNC patients have historically been treated with photon-based …

Use of proton beam therapy has expanded, with the number of proton centres rapidly
increasing not only in the USA but also worldwide. The physical characteristics of the proton …

Modern conformal radiation therapy using techniques such as modulation, image guidance
and motion management have changed the face of radiotherapy today offering superior …

Simple Summary Nasopharyngeal carcinoma (NPC) is commonly treated using high-dose
radiotherapy. Careful radiotherapy planning is crucial for the eradication of cancer cells …

Nasopharyngeal carcinoma (NPC) is a malignancy with unique clinical biological profiles
such as associated Epstein-Barr virus infection and high radiosensitivity. Radiotherapy has …